AIP
MRK icon

Arrowpoint Investment Partners’s Merck MRK Stock Holding History

Arrowpoint Investment Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-46,686
Closed -$4.91M – 119
2025
Q4 		$4.91M Buy
+46,686
New +$4.38M 0.72% 16
2025
Q2 		– Sell
-14,890
Closed -$1.34M – 565
2025
Q1 		$1.34M Buy
+14,890
New +$1.39M 0.16% 155

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Arrowpoint Investment Partners's MRK Position: Q1 2026 in Review

Arrowpoint Investment Partners sold out of Merck (MRK) in Q1 2026, closing a stake of 46,686 shares — an estimated $4.91M sold.

Arrowpoint Investment Partners first reported a position in MRK in Q1 2025 and held it in 2 quarters. The position peaked at $4.91M in Q4 2025. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Arrowpoint Investment Partners reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
  • Arrowpoint Investment Partners sold 46,686 Merck shares in Q1 2026, an estimated $4.91M.
  • Arrowpoint Investment Partners first reported a position in Merck in Q1 2025 and held it in 2 quarters.
  • Arrowpoint Investment Partners's Merck position peaked at $4.91M in Q4 2025.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Arrowpoint Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.